Index your Journal on RJRIndex — A product by ResearchJournalRank.com Index Now
34,970+ Journals Indexed Journal Suggester  |  Paper Finder  |  Compare Journals
Home › Therapeutic Advances in Psychopharmacology

Therapeutic Advances in Psychopharmacology

Q1 Journal Open Access Scopus Active Journal
Country
United Kingdom
Western Europe
Subject Area and Category
Medicine
└ Pharmacology (medical) Q1
└ Psychiatry and Mental Health Q1
SJR 2025
1.321
Q1
SJR Score
H-Index
52
Citations / Doc (2yr)
4.39
Total Docs. (latest)
34
Total Citations (3yr)
461
Publication type
Journals
ISSN
20451261, 20451253
Coverage
2011-2026
Journal Rank
#3,070
Advertisement

Subject Categories

Pharmacology (medical) Q1
Psychiatry and Mental Health Q1

Subject Areas

Aims & Scope

Therapeutic Advances in Psychopharmacology delivers the highest quality peer-reviewed open access articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of psychopharmacology. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in psychopharmacology, providing an online forum for rapid dissemination of recent research and perspectives in this area. The editors welcome original research articles across all areas of psychopharmacology. The journal is dedicated to publishing clinical research. We do not publish preclinical research, including basic laboratory research and animal studies.

Abstracting & Indexing

Scopus Google Scholar Directory of Open Access Journals (DOAJ) Web of Science Embase

Detailed Metrics

Total Docs. (latest) 34
Total Docs. (3 years) 111
Total Refs. 1,838
Total Citations (3 years) 461
Citable Docs. (3 years) 103
Citations / Doc. (2 years) 4.39
Ref. / Doc. 54.06
% Female 39.8%

Metrics Visualization

Latest year data vs 3-year cumulative figures

Publication & Citation Trend

Loading trend data from Crossref...

Top 10 Most Cited Articles

Loading articles...

Frequently Asked Questions

What is the impact factor of Therapeutic Advances in Psychopharmacology?

The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Therapeutic Advances in Psychopharmacology has an SJR of 1.321 and is ranked Q1.

What is the SJR and quartile of Therapeutic Advances in Psychopharmacology?

Therapeutic Advances in Psychopharmacology has an SJR (SCImago Journal Rank) of 1.321 and its best quartile is Q1.

What is the H-index of Therapeutic Advances in Psychopharmacology?

The H-index of Therapeutic Advances in Psychopharmacology is 52, meaning 52 of its articles have each been cited at least 52 times.

Is Therapeutic Advances in Psychopharmacology indexed in Scopus?

Yes. Therapeutic Advances in Psychopharmacology is active in Scopus (Scopus Source List, August 2026).

Advertisement

Journal Information

SJR1.321
Best QuartileQ1
H Index52
ISSN20451261, 20451253
PublisherSAGE Publications Inc.
CountryUnited Kingdom
RegionWestern Europe
Coverage2011-2026
Open AccessYes
TypeJournal
Rank#3,070

Similar Journals

View all Medicine journals

Embed This Journal

Add this journal's ranking badge to your website:

<iframe src="https://researchjournalrank.com/widget.php?id=3624" style="border:1px solid #e0e0e0;border-radius:8px;width:100%;max-width:320px;height:200px" frameborder="0"></iframe>
Preview:

Researcher Reviews

Write a Review

No reviews yet for this journal.

Be the first to share your experience!

Share Your Experience

Your review will be published after moderation. Email will not be displayed publicly.

★ ★ ★ ★ ★
★ ★ ★ ★ ★
★ ★ ★ ★ ★
★ ★ ★ ★ ★